• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 SNEDDS 中,应用体外 Fick 第一定律、脂肪酶解和体内大鼠模型对 BCS II 类药物的口服吸收进行比较。

Comparisons of in vitro Fick's first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS.

机构信息

Department of Pharmaceutics, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.

Department of Pharmacy of Chinese Materia Medica, School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, People's Republic of China.

出版信息

Int J Nanomedicine. 2019 Jul 23;14:5623-5636. doi: 10.2147/IJN.S203911. eCollection 2019.

DOI:10.2147/IJN.S203911
PMID:31440045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6664859/
Abstract

PURPOSE

The objective of this study was to compare the in vitro Fick's first law, in vitro lipolysis, and in vivo rat assays for oral absorption of Biopharmaceutical Classification Systems Class II (BCS II) drugs in self-nanoemulsifying drug delivery system (SNEDDS), and studied drugs and oils properties effects on the absorption.

METHODS

The transport abilities of griseofulvin (GRI), phenytoin (PHE), indomethacin (IND), and ketoprofen (KET) in saturated water solutions and SNEDDS were investigated using the in vitro Madin-Darby canine kidney cell model. GRI and cinnarizine (CIN) in medium-chain triglycerides (MCT)-SNEDDS and long-chain triglycerides (LCT)-SNEDDS were administered in the in vivo SD rat and in vitro lipolysis models to compare the oral absorption and the distribution behaviors in GIT and build an in vitro-in vivo correlation (IVIVC).

RESULTS

In the cell model, the solubility of GRI, PHE, IND, and KET increased 6-8 fold by SNEDDS, but their permeability were only 18%, 4%, 8%, and 33% of those of their saturated water solutions, respectively. However, in vivo absorption of GRI-SNEDDS was twice that of the GRI suspension and those of CIN-SNEDDS were 15-21 fold those of the CIN suspension. In the lipolysis model, the GRI% in aqueous and pellet phases of MCT were similar to that in LCT. In contrast, the CIN% in the aqueous and pellet phases were decreased but that of the lipid phase increased. In addition, an IVIVC was found between the CIN% in the lipid phase and in vivo relative oral bioavailability ( ).

CONCLUSION

The in vitro cell model was still a suitable tool to study drug properties effects on biofilm transport and SNEDDS absorption mechanisms. The in vitro lipolysis model provided superior oral absorption simulation of SNEDDS and helped to build correlation with in vivo rats. The oral drug absorption was affected by drug and oil properties in SNEDDS.

摘要

目的

本研究旨在比较体外菲克第一定律、体外脂肪分解和体内大鼠试验,以评估生物药剂学分类系统(BCS)Ⅱ类药物在自微乳给药系统(SNEDDS)中的口服吸收情况,并研究药物和油类性质对吸收的影响。

方法

采用体外马-达比犬肾细胞模型,研究灰黄霉素(GRI)、苯妥英(PHE)、吲哚美辛(IND)和酮洛芬(KET)在饱和水溶液和 SNEDDS 中的转运能力。将 GRI 和肉桂嗪(CIN)分别置于中链甘油三酯(MCT)-SNEDDS 和长链甘油三酯(LCT)-SNEDDS 中,通过体内 SD 大鼠和体外脂肪分解模型进行给药,比较口服吸收和在胃肠道中的分布行为,并建立体外-体内相关性(IVIVC)。

结果

在细胞模型中,GRI、PHE、IND 和 KET 的溶解度通过 SNEDDS 分别提高了 6-8 倍,但它们的通透性仅为其饱和水溶液的 18%、4%、8%和 33%。然而,GRI-SNEDDS 的体内吸收是 GRI 混悬液的两倍,CIN-SNEDDS 的吸收是 CIN 混悬液的 15-21 倍。在脂肪分解模型中,MCT 中的 GRI 在水相和颗粒相的比例与 LCT 相似。相比之下,CIN 在水相和颗粒相的比例降低,但在脂质相的比例增加。此外,还发现 CIN 在脂质相的比例与体内相对口服生物利用度()之间存在 IVIVC。

结论

体外细胞模型仍然是研究药物性质对生物膜转运和 SNEDDS 吸收机制影响的合适工具。体外脂肪分解模型为 SNEDDS 的口服吸收提供了更优越的模拟,并有助于与体内大鼠建立相关性。SNEDDS 中的药物和油类性质影响药物的口服吸收。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/dd43c4d1631b/IJN-14-5623-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/69ed388fc5a2/IJN-14-5623-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/562e244a2d00/IJN-14-5623-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/54408da82ef8/IJN-14-5623-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/2b501174f2df/IJN-14-5623-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/e6390a710a95/IJN-14-5623-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/3a9557ed294c/IJN-14-5623-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/dd43c4d1631b/IJN-14-5623-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/69ed388fc5a2/IJN-14-5623-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/562e244a2d00/IJN-14-5623-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/54408da82ef8/IJN-14-5623-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/2b501174f2df/IJN-14-5623-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/e6390a710a95/IJN-14-5623-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/3a9557ed294c/IJN-14-5623-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a258/6664859/dd43c4d1631b/IJN-14-5623-g0007.jpg

相似文献

1
Comparisons of in vitro Fick's first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS.在 SNEDDS 中,应用体外 Fick 第一定律、脂肪酶解和体内大鼠模型对 BCS II 类药物的口服吸收进行比较。
Int J Nanomedicine. 2019 Jul 23;14:5623-5636. doi: 10.2147/IJN.S203911. eCollection 2019.
2
Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations.桂利嗪的载药量和物理形态对新型自乳化药物递送系统给药方案的影响:体内和体外评价
AAPS J. 2017 Mar;19(2):587-594. doi: 10.1208/s12248-016-0038-4. Epub 2017 Jan 9.
3
Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.肉桂嗪在犬体内的生物利用度:固体脂质纳米分散体载药量的影响及其与体外脂肪分解过程中肉桂嗪增溶作用的相关性。
Pharm Res. 2013 Dec;30(12):3101-13. doi: 10.1007/s11095-013-1145-x. Epub 2013 Aug 15.
4
The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens.两种体外脂肪分解模型(反映人体和大鼠胃肠条件)预测 SNEDDS 给药方案体内性能的能力。
Eur J Pharm Biopharm. 2018 Mar;124:116-124. doi: 10.1016/j.ejpb.2017.12.014. Epub 2017 Dec 27.
5
Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.采用体外脂肪酶水解和 SPECT/CT 体内成像技术了解贝特类药物从基于脂质的药物传递系统的口服吸收。
J Control Release. 2020 Jan 10;317:375-384. doi: 10.1016/j.jconrel.2019.11.024. Epub 2019 Nov 23.
6
Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.进食和禁食状态下胃肠道的体外脂肪分解:传统片剂、自乳化药物递送系统(SNEDDS)和固化SNEDDS的体外与体内关系
Eur J Pharm Sci. 2014 Jun 16;57:232-9. doi: 10.1016/j.ejps.2013.09.007. Epub 2013 Sep 18.
7
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).新型超饱和自微乳给药系统(super-SNEDDS)的体外和体内性能。
J Control Release. 2012 May 30;160(1):25-32. doi: 10.1016/j.jconrel.2012.02.027. Epub 2012 Mar 3.
8
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex.载有去甲紫堇碱-磷脂复合物的自微乳药物传递系统吸收增强的机制研究。
Int J Nanomedicine. 2019 Sep 2;14:7095-7106. doi: 10.2147/IJN.S211905. eCollection 2019.
9
Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.开发自纳米乳化药物递送系统以提高非诺贝特(一种难溶性药物)的溶解度和口服生物利用度。
Int J Nanomedicine. 2016 Jun 14;11:2829-38. doi: 10.2147/IJN.S104187. eCollection 2016.
10
Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) Containing Rice Bran Oil for Enhanced Fenofibrate Oral Delivery: In Vitro Digestion, Ex Vivo Permeability, and In Vivo Bioavailability Studies.含米糠油的自微乳药物传递系统(SNEDDS)增强非诺贝特口服递送:体外消化、离体透过性和体内生物利用度研究。
AAPS PharmSciTech. 2020 Jul 28;21(6):208. doi: 10.1208/s12249-020-01765-2.

引用本文的文献

1
Metformin hydrochloride entrapment in sorbitan monostearate for intestinal permeability enhancement and pharmacodynamics.盐酸二甲双胍包封于山梨醇单硬脂酸酯中以增强肠道通透性和药效学。
Sci Rep. 2021 Oct 11;11(1):20153. doi: 10.1038/s41598-021-99649-3.
2
and correlation for lipid-based formulations: Current status and future perspectives.基于脂质的制剂的相关性:现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2469-2487. doi: 10.1016/j.apsb.2021.03.025. Epub 2021 Mar 21.
3
Comparison of Three Different Aqueous Microenvironments for Enhancing Oral Bioavailability of Sildenafil: Solid Self-Nanoemulsifying Drug Delivery System, Amorphous Microspheres and Crystalline Microspheres.

本文引用的文献

1
Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations.药物物理化学性质对脂解触发药物超饱和和从脂质体制剂中沉淀的影响。
Mol Pharm. 2018 Oct 1;15(10):4733-4744. doi: 10.1021/acs.molpharmaceut.8b00699. Epub 2018 Sep 7.
2
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
3
Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems.
三种不同水介质环境对提高西地那非口服生物利用度的比较:固体自微乳药物传递系统、无定形微球和结晶微球。
Int J Nanomedicine. 2021 Aug 24;16:5797-5810. doi: 10.2147/IJN.S324206. eCollection 2021.
4
Liquid and Solid Self-Emulsifying Drug Delivery Systems (SEDDs) as Carriers for the Oral Delivery of Azithromycin: Optimization, In Vitro Characterization and Stability Assessment.液体和固体自乳化药物递送系统(SEDDs)作为阿奇霉素口服递送的载体:优化、体外表征及稳定性评估
Pharmaceutics. 2020 Nov 4;12(11):1052. doi: 10.3390/pharmaceutics12111052.
5
Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.包含脱氧胆酸衍生物 - 脂质复合物的依托泊苷多重纳米乳剂的口服生物利用度增强。
Drug Deliv. 2020 Dec;27(1):1501-1513. doi: 10.1080/10717544.2020.1837293.
6
A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied.一种非脂解纳米乳通过减少雷洛昔芬的首过代谢来提高口服生物利用度,相关吸收机制正在研究中。
Int J Nanomedicine. 2020 Aug 26;15:6503-6518. doi: 10.2147/IJN.S259993. eCollection 2020.
7
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.过饱和自乳化药物递送系统的现状
Pharmaceutics. 2020 Apr 16;12(4):365. doi: 10.3390/pharmaceutics12040365.
用于评估脂质体药物递送系统生物利用度的体外同时脂解/渗透模型。
Eur J Pharm Biopharm. 2017 Aug;117:300-307. doi: 10.1016/j.ejpb.2017.05.001. Epub 2017 May 3.
4
Transport of lipid nano-droplets through MDCK epithelial cell monolayer.脂质纳米液滴通过MDCK上皮细胞单层的转运。
Colloids Surf B Biointerfaces. 2017 May 1;153:237-243. doi: 10.1016/j.colsurfb.2017.02.024. Epub 2017 Feb 21.
5
Regenerated cellulose capsules for controlled drug delivery: Part IV. In-vitro evaluation of novel self-pore forming regenerated cellulose capsules.用于控释给药的再生纤维素胶囊:第四部分。新型自造孔再生纤维素胶囊的体外评价
Eur J Pharm Sci. 2017 Jan 15;97:227-236. doi: 10.1016/j.ejps.2016.11.027. Epub 2016 Dec 2.
6
In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption.脂溶性弱碱桂利嗪在胃肠道中的过饱和/沉淀/再溶解行为的体内评价:口服吸收的关键过程
Eur J Pharm Sci. 2017 Jan 1;96:464-471. doi: 10.1016/j.ejps.2016.10.023. Epub 2016 Oct 20.
7
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.膳食脂肪和药用脂质辅料会增加口服大麻及大麻类药物的全身暴露量。
Am J Transl Res. 2016 Aug 15;8(8):3448-59. eCollection 2016.
8
Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.基于脂质的制剂可使模型中水溶性差的弱碱性药物桂利嗪在体外消化过程中以无定形盐形式沉淀。
Mol Pharm. 2016 Nov 7;13(11):3783-3793. doi: 10.1021/acs.molpharmaceut.6b00594. Epub 2016 Sep 27.
9
Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.测量纳米颗粒结合药物肠道吸收方法的进展
Int J Mol Sci. 2016 Jul 21;17(7):1171. doi: 10.3390/ijms17071171.
10
Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin.磷脂复合物与自乳化微乳联合使用以改善BCS IV类化合物黄芩苷的口服吸收
Acta Pharm Sin B. 2014 Jun;4(3):217-26. doi: 10.1016/j.apsb.2014.03.002. Epub 2014 Apr 29.